Renate Braun-Klauser - Publications

Individualizing antihypertensive therapy in diabetes mellitus. Guidelines of the Austrian Diabetes Association (Update 2026)

Journal: Wiener klinische Wochenschrift

Published: January 06, 2026

Venous Thromboembolism and Vascular Access Thrombosis in Patients on Hemodialysis: Incidence, Risk Factors, and Use of Antithrombotic Agents.

Journal: Thrombosis and haemostasis

Published: September 24, 2025

Antibodies to oxidation-specific epitopes characterize hemodialysis patients protected from cardiovascular events.

Journal: Thrombosis research

Published: May 20, 2025

Telomere Length Is Associated with Increased Risk of Cardiovascular Events in Patients with End-Stage Kidney Disease on Hemodialysis.

Journal: Cardiorenal medicine

Published: March 22, 2024

Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (update 2023)

Journal: Wiener klinische Wochenschrift

Published: March 03, 2023

Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 29, 2022

Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study.

Journal: Thrombosis journal

Published: July 04, 2022

Bleeding Risk Assessment in End-Stage Kidney Disease: Validation of Existing Risk Scores and Evaluation of a Machine Learning-Based Approach.

Journal: Thrombosis and haemostasis

Published: January 31, 2022

Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 17, 2021

Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.

Journal: Atherosclerosis

Published: September 27, 2019

Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).

Journal: Thrombosis research

Published: April 19, 2017

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).

Journal: PloS one

Published: August 01, 2016